Liposomal Irinotecan and Leucovorin/5-fluorouracil Plus Bevacizumab in Metastatic Colorectal Cancer

Clinical trial NCT06184698 · RECRUITING

Trial details

NCT number: NCT06184698
Sponsor: Hebei Medical University Fourth Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2024-01-01
Primary completion: 2026-02-01
Enrollment: 173

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.